Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Catalent, Inc. (CTLT)  
$56.20 0.33 (0.58%) as of 4:30 Wed 5/8


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 207,851,000
Market Cap: 11.68(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $31.86 - $59.82
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Catalent is a holding company. Through its subsidiaries, Co. has two operating and reporting segments: Biologics and Pharma and Consumer Health. The Biologics segment provides development and manufacturing for biologic proteins; cell, gene, and other nucleic acid therapies; plasmid DNA; induced pluripotent stem cells; and vaccines. The Pharma and Consumer Health segment comprises Co.'s capabilities for oral solids, softgel formulations, Zydis® fast-dissolve technologies, and gummy, soft chew, and lozenge dosage forms; formulation, development, and manufacturing platforms for oral, nasal, inhaled, and topical dose forms; and clinical trial development and supply services.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,000 1,000
Total Buy Value $0 $0 $49,980 $49,980
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 387 387 11,063 116,582
Total Sell Value $21,749 $21,749 $512,581 $11,151,362
Total People Sold 1 1 12 18
Total Sell Transactions 1 1 25 69
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 821
  Page 10 of 33  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Fasman Steven L SVP & General Counsel   •       –      –    2021-10-04 4 AS $128.56 $4,479,975 D/D (34,714) 57,133 -23%     
   Fasman Steven L SVP & General Counsel   •       –      –    2021-10-04 4 OE $36.02 $889,050 D/D 17,259 91,847     -
   Schmidt Kay A SVP, Technical Operations   •       –      –    2021-10-04 4 AS $131.25 $287,569 D/D (2,191) 13,778 -23%     
   Chiminski John R Chair & CEO   •       •      –    2021-10-01 4 AS $127.34 $19,979,610 D/D (152,637) 142,073 -25%     
   Chiminski John R Chair & CEO   •       •      –    2021-10-01 4 OE $34.91 $2,986,973 D/D 75,838 294,710     -
   Grippo Michael J SVP, Strategy & Corp. Dev.   •       –      –    2021-10-01 4 AS $128.00 $270,557 D/D (2,055) 12,502 -25%     
   Pravda Ricardo SVP & Chief HR Officer   •       –      –    2021-10-01 4 AS $132.68 $650,928 D/D (4,906) 11,747 -25%     
   Pravda Ricardo SVP & Chief HR Officer   •       –      –    2021-10-01 4 OE $54.94 $241,694 D/D 3,818 16,653     -
   Chiminski John R Chair & CEO   •       •      –    2021-09-01 4 GD $0.00 $0 D/D 11,000 218,872     -
   Kreuzburg Christa Director   –       •      –    2021-08-27 4 D $129.85 $25,840 D/D (199) 8,566     -
   Gunther Scott SVP, Quality & Reg. Affairs   •       –      –    2021-08-27 4 AS $130.29 $545,725 D/D (4,173) 18,062 -11%     
   Chiminski John R Chair & CEO   •       •      –    2021-08-27 4 AS $130.41 $5,830,711 D/D (44,488) 229,872 -11%     
   Grippo Michael J SVP, Strategy & Corp. Dev.   •       –      –    2021-08-27 4 AS $130.29 $222,661 D/D (1,698) 14,557 -11%     
   Gennadios Aristippos President Softgel & Oral Tech   •       –      –    2021-08-27 4 AS $130.29 $296,619 D/D (2,262) 57,481 -11%     
   Castellano Thomas P SVP, Chief Financial Officer   •       –      –    2021-08-27 4 AS $130.29 $274,458 D/D (2,093) 17,705 -11%     
   Maselli Alessandro President & COO   •       –      –    2021-08-27 4 AS $130.29 $490,824 D/D (3,743) 25,899 -11%     
   Pravda Ricardo SVP & Chief HR Officer   •       –      –    2021-08-27 4 AS $130.29 $90,742 D/D (692) 12,835 -11%     
   Fasman Steven L SVP & General Counsel   •       –      –    2021-08-27 4 AS $130.29 $801,344 D/D (6,111) 74,588 -11%     
   Hopson Ricky VP, Chief Accounting Officer   •       –      –    2021-08-27 4 AS $130.29 $192,894 D/D (1,471) 19,398 -11%     
   Arnold Jonathan Pres. Oral & Specialty Deliv.   •       –      –    2021-08-27 4 AS $130.29 $59,271 D/D (452) 46,745 -11%     
   Schmidt Kay A SVP, Technical Operations   •       –      –    2021-08-27 4 AS $130.29 $108,183 D/D (825) 15,969 -11%     
   Gunther Scott SVP, Quality & Reg. Affairs   •       –      –    2021-08-26 4 A $0.00 $0 D/D 6,052 22,235     -
   Chiminski John R Chair & CEO   •       •      –    2021-08-26 4 A $0.00 $0 D/D 105,418 274,360     -
   Grippo Michael J SVP, Strategy & Corp. Dev.   •       –      –    2021-08-26 4 A $0.00 $0 D/D 4,984 16,255     -
   Gennadios Aristippos President Softgel & Oral Tech   •       –      –    2021-08-26 4 A $0.00 $0 D/D 8,008 59,743     -
  821 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 10 of 33
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us